What is TriTren 225?
TriTren 225 combines three trenbolone esters in one oil (225mg/ml) that differ in release speed. The principle is the same as TrenMix, just over three esters instead of two. The compound remains trenbolone, one of the most potent anabolic steroids.
Honestly: harsh profile, not a beginner compound. Anabolic steroid, not a peptide.
Comparison
Single esters and blends
Always the same trenbolone at the same receptors, only the esters differ, as stated in the TPD lexicon. Tap a card to open its entry.
The ester only changes how fast trenbolone leaves the depot. There is no human study comparing the esters. 8
How it works
Trenbolone binds the androgen receptor very strongly, increases muscle mass and strength, does not aromatize but can raise prolactin. The three esters provide an even, sustained compound level over different release speeds.
Where it acts
Where trenbolone acted in studies
Tap a point or a card. Grey = seen in studies, mostly in rats or by survey.
- Brain and mood
Irritability, mood swings and aggression more common in surveys than with other anabolic steroids10
Observed in trials - Heart
Concern about the heart in 54.4% of men with trenbolone, 31.2% without (survey)10
Observed in trials - Blood lipids
HDL cholesterol -57%, LDL cholesterol -78%, triglycerides -62% (rats)7
Observed in trials - Skeletal muscle
Muscle fibre cross-section +94%, satellite cells +178% after castration (rats)6
Observed in trials - Bone
Bone density fully preserved after castration, femoral neck 28% stronger (rats)5
Observed in trials - Fat tissue
Fat mass -37% in 6 weeks, control animals +34% (rats)7
Observed in trials - Hormone axis and prostate
Own sex hormones suppressed, prostate benignly enlarged (rats)7
Observed in trials
Known targets8
Compound CHEMBL197309: two described targets, type of action on each card.
- Gene
- AR
- UniProt
- P10275
- ChEMBL
- CHEMBL1871
- Action
- Binds about as strongly as DHT (human receptor, lab)
Use
Dosing
Dosing
Dosing, titration and syringe
Loading the dosing information …
- Getting started and stepping up, drawn as a staircase
- Units on the U-100 syringe for every step
- How long one vial lasts
What the research shows
Trenbolone is described as a very potent anabolic steroid (Yarrow, 2010), without human approval. Performance doses are not study-proven. The three-ester variant is only a formulation matter, not its own evidence base.
Study results
What the trials measured
Interactive: switch tabs, tap points, show or hide arms. Arms are named relative to each other, no dosing advice.
Muscle after castration (rats)6
Increase compared with castrated rats without hormone after 29 days, pelvic muscle
Rats, 41 animals in four groups. Testosterone was given in a much higher amount than trenbolone. Despite more myostatin the muscle grew under both hormones.
Prostate (rats)45
Change in prostate mass compared with sham-operated rats
Low trenbolone levels kept prostate and haemoglobin at the sham level. In the older rats the value -20 is not statistically significant, testosterone nearly doubled the prostate there. Not transferable to humans.
Body and blood lipids (rats)7
Non-castrated rats, 6 weeks of trenbolone via a pump under the skin
12 rats. The control animals gained fat over 6 weeks, under trenbolone fat mass fell. The prostate grew benignly, the body's own sex hormones were suppressed. Rat values for blood lipids do not transfer to humans.
Research status
Where the research stands
There is no registered human trial of trenbolone. The data on TriTren 225 come from animal studies, lab experiments and surveys of users. As of 26 Oct 2026. 12
- Preclinical Rats: muscle, bone, fat and prostate
- Phase 1 no registered trial
- Phase 2 no registered trial
- Phase 3 no registered trial
- Approval not yet
So far there is no registered trial in humans. 12
Side effects
- Harsh tren profile: sleep problems, night sweats, irritability, aggression.
- Possible prolactin rise (see cabergoline), strong axis suppression.
- Negative lipid shift, cardiovascular load, conditioning losses.
Tolerability
Self-reported concerns in a survey
Out of 100 men, how many reported the concern in an online survey. Self-report, no medical measurement, no placebo.
| Event | With trenbolone (237 men) | Other anabolic steroids without trenbolone (909 men) |
|---|---|---|
| Concern about the heart10 | 54% | 31% |
| Hair loss10 | 43% | 28% |
| Concern about the liver10 | 42% | 22% |
| Gynaecomastia10 | 33% | 21% |
| Restlessness and irritability10 | 29% | 13% |
| Decreased sexual function10 | 25% | 15% |
| Anger and aggression10 | 21% | 9% |
Values from the tables of the study (full text), rounded in the chart. The trenbolone group also took oral anabolic steroids far more often (79.7 vs 38.4 percent), so a concern cannot be assigned to one compound with certainty. Several concerns occurred together more often with trenbolone.10
Practice
-
Not a beginner compound, dose low, keep it short.
-
Watch bloodwork and prolactin, plan a post-cycle.
-
Banned in official competition (WADA S1).
Storage
Store at room temperature, cool and protected from light, out of reach of children. Keep the original bottle closed and mind the expiry date.